Home › T-Cell Lymphoma › Pennsylvania › Philadelphia
T-Cell Lymphoma clinical trials in Philadelphia, PA
11 studies for T-Cell Lymphoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
RecruitingPhase 1/2
- University of Pennsylvania, Philadelphia
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
RecruitingPhase 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi away
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi away
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RecruitingPhase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CD45BE-HSPC + CART-45 Cells
RecruitingPhase 1
- University of Pennsylvania, Philadelphia
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
RecruitingPhase 1
- Children's Hospital of Philadelphia, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
- Children's Hospital of Philadelphia, Philadelphia
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- University of Pennsylvania (Data Collection Only), Philadelphia
- Thomas Jefferson University Hospital (Data collection only), Philadelphia
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
RecruitingPhase 1
- University of Pennsylvania - Perelman Center, Philadelphia
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
RecruitingPhase 1
- University of Pennsylvania - Abramson Caner Center, Philadelphia
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's Hospital of Philadelphia, Philadelphia
T-Cell Lymphoma trials in other cities
- New York City, NY14 studies
- Boston, MA10 studies
- Baldwin Park, CA10 studies
- Houston, TX9 studies
- Atlanta, GA8 studies
- Rochester, MN6 studies
- Chicago, IL6 studies
- Columbus, OH6 studies
- Seattle, WA6 studies
- New Haven, CT6 studies
- Miami, FL5 studies
- Portland, OR5 studies
Other studies in Philadelphia
- Cancer (all types)60 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.